InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+13.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Paul Steven M, 董事长兼首席执行官. Insider active across 5 companies, notably Karuna Therapeutics, Inc.. Cumulatively, 11 disclosures have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €697k. History available since 17 August 2021. The latest transaction was filed on 12 September 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Paul Steven M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
28,284 股@ US$24.4996100.0% 占其流量Common StockSEC:0001193125-25-203537:0
标准退出：2025年12月11日 (T+90)
2,046 股@ US$330.004.1% 占其流量Common StockSEC:0001140361-24-013933:0
47,378 股@ US$315.1891.6% 占其流量Common StockSEC:0000950170-24-024999:0
27,510 股@ US$7.271.2% 占其流量Common StockSEC:0000950170-24-020397:0
804 股@ US$317.141.6% 占其流量Common StockSEC:0000950170-24-013963:0
106,485 股0Common StockSEC:0000899243-23-004747:0
5 股@ US$38.167571.1% 占其流量Common StockSEC:0001562180-22-007940:0
15,000 股@ US$11.33100.0% 占其流量Common StockSEC:0001735276-22-000039:0
1 股@ US$43.3616.9% 占其流量Common StockSEC:0001562180-21-007019:0
1,183 股@ US$105.630.7% 占其流量Common StockSEC:0001593968-21-001992:0
标准退出：2021年11月15日 (T+90)
10,000 股Common StockSEC:0001104659-16-090139:0
标准退出：2016年4月13日 (T+90)
11 条申报中的 11 条
About Paul Steven M
PAUL STEVEN M is Président-Directeur Général and is reported as a director of Karuna Therapeutics, Inc., Sage Therapeutics, Inc., Rapport Therapeutics, Inc. and ALNYLAM PHARMACEUTICALS, INC., as well as President and CEO of Voyager Therapeutics, Inc. He has 11 filings in total, and across the sampled recent filings, buys amount to EUR 697223 and sells to EUR 620423, over the period from 2016-01-15 to 2025-09-15.
